S M Marks
Overview
Explore the profile of S M Marks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
439
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marks S, Winston C
Int J Tuberc Lung Dis
. 2024 Apr;
28(4):214-215.
PMID: 38563338
No abstract available.
2.
Beeler Asay G, Woodruff R, Sanderson D, Fisher C, Marks S, Green V, et al.
Int J Tuberc Lung Dis
. 2024 Jan;
28(1):21-28.
PMID: 38178297
Between October 2016 and March 2019, Lynn Community Health Center in Massachusetts implemented a targeted latent TB infection testing and treatment (TTT) program, increasing testing from a baseline of 1,200...
3.
Schmit K, Shah N, Kammerer S, Bamrah Morris S, Marks S
J Racial Ethn Health Disparities
. 2020 Feb;
7(5):865-873.
PMID: 32060748
Background: Persons living with HIV are more likely to have tuberculosis (TB) disease attributed to recent transmission (RT) and to die during TB treatment than persons without HIV. We examined...
4.
Aslam M, Owusu-Edusei K, Marks S, Asay G, Miramontes R, Kolasa M, et al.
Int J Tuberc Lung Dis
. 2019 Jan;
22(12):1495-1504.
PMID: 30606323
Objective: To estimate the number and cost of hospitalizations with a diagnosis of active tuberculosis (TB) disease in the United States. Methods: We analyzed the 2014 National In-Patient Sample using...
5.
Owusu-Edusei K, Marks S, Miramontes R, Stockbridge E, Winston C
Int J Tuberc Lung Dis
. 2017 Mar;
21(4):398-404.
PMID: 28284254
Objective: To determine hospitalization expenditures for tuberculosis (TB) disease among privately insured patients in the United States. Methods: We extracted TB hospital admissions data from the 2010-2014 MarketScan® commercial database...
6.
Castro K, Marks S, Hill A, Chen M, Miramontes R, Winston C, et al.
Int J Tuberc Lung Dis
. 2017 Feb;
21(1):120-121.
PMID: 28157476
No abstract available.
7.
Castro K, Marks S, Chen M, Hill A, Becerra J, Miramontes R, et al.
Int J Tuberc Lung Dis
. 2016 Jun;
20(7):926-33.
PMID: 27287646
Background: Following a concerted public health response to the resurgence of tuberculosis (TB) in the United States in the late 1980s, annual TB incidence decreased substantially. However, no estimates exist...
8.
Marks S, Hirsch-Moverman Y, Salcedo K, Graviss E, Oh P, Seaworth B, et al.
Int J Tuberc Lung Dis
. 2016 Mar;
20(4):435-41.
PMID: 26970150
Objective: A population-based study of 135 multidrug-resistant tuberculosis (MDR-TB) patients reported to the Centers for Disease Control and Prevention (CDC) during 2005-2007 found 73% were hospitalized. We analyzed factors associated...
9.
Pagaoa M, Royce R, Chen M, Golub J, Davidow A, Hirsch-Moverman Y, et al.
Int J Tuberc Lung Dis
. 2015 Nov;
19(12):1485-92.
PMID: 26614190
Setting: Tuberculosis (TB) patients and their contacts enrolled in nine states and the District of Columbia from 16 December 2009 to 31 March 2011. Objective: To evaluate characteristics of TB...
10.
Shepardson D, Marks S, Chesson H, Kerrigan A, Holland D, Scott N, et al.
Int J Tuberc Lung Dis
. 2013 Nov;
17(12):1531-7.
PMID: 24200264
Setting: A large randomized controlled trial recently showed that for treating latent tuberculous infection (LTBI) in persons at high risk of progression to tuberculosis (TB) disease, a 12-dose regimen of...